IMBiotechnologies Ltd. (“IMB” or the “Company”) today announced that it has received Heath Canada approval for its lead product, Ekobi™ Embolization Microspheres (“Ekobi”), for the treatment of hypervascularized tumors (“HVT”) and benign...
Read moreClick here to find more details This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and...
Read moreChinese venture capital investment into US biotech companies in the first half of the year has already surpassed the record set for the whole of 2017, underlining Beijing’s focus on medicine as a strategic sector — a development that has flown...
Read moreNAI500 is excited to introduce three new companies that have joined our growing online investor platform. Visit their profiles below to learn what investment opportunities they bring. Takung Art Co Ltd (NYSE AMERICAN:TKAT) ir.takungart.com Takung...
Read moreRichmond, BC, May 28 2018 – Eastwood Bio-medical Canada Inc. (TSXV: EBM) (the “Company”)is pleased to highlight the accomplishments of a few major milestones as the BC based company prepares to finalize the its successful expansion of...
Read moreWith the rise of the Chinese middle class, “the love of beauty, the fear of death, and the lack of love” have become important psychological driving forces for consumers and while many sectors are seeing explosive growth, the health care industry...
Read more
